MIST (Milestone Pharmaceuticals) Buyback Yield %: -6.63 (As of Jun. 30, 2026)


MIST Milestone Pharmaceuticals Inc MIST
26 GF Score
Price $1.36
! 6 Warning Signs
View Full Analysis

What is Milestone Pharmaceuticals Buyback Yield %?

Milestone Pharmaceuticals MIST +2.65% 26 Buyback Yield % is -6.63 as of Jun. 30, 2026. GuruFocus rates MIST with a GF Score™ of 26/100. The stock has 6 warning signs investors should review. Among 742 Biotechnology companies, Milestone Pharmaceuticals ranks better than 54.45% on this metric.

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Milestone Pharmaceuticals's current buyback yield was -6.63%.

Milestone Pharmaceuticals Buyback Yield % Related Terms

Milestone Pharmaceuticals Buyback Yield % Historical Data

* Premium members only.

The historical data trend for Milestone Pharmaceuticals's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Milestone Pharmaceuticals Buyback Yield % Chart

Milestone Pharmaceuticals Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Buyback Yield %
Get a 7-Day Free Trial Premium Member Only 0.00 -1.94 0.00 -21.65 -23.77

Milestone Pharmaceuticals Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.65 0.00 0.00 -23.77 -7.77

MIST vs TNYA, TLSA, NRXP: Buyback Yield % Comparison

For the Biotechnology subindustry, Milestone Pharmaceuticals's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Milestone Pharmaceuticals Buyback Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Milestone Pharmaceuticals's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Milestone Pharmaceuticals's Buyback Yield % falls into.


MIST
26GF Score
Milestone Pharmaceuticals Inc MIST
Buyback Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Milestone Pharmaceuticals Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Milestone Pharmaceuticals's Buyback Yield for the fiscal year that ended in Dec. 2025 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (0 + 51.009) / 214.59672
=-23.77%

Milestone Pharmaceuticals's annualized Buyback Yield for the quarter that ended in Mar. 2026 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- (0 + 10.89) / 140.17486
=-7.77%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Frequently Asked Questions Learn more about Buyback Yield % →
What does a Buyback Yield % of -6.63 mean?
Milestone Pharmaceuticals (MIST) has a Buyback Yield % of -6.63 as of Jun. 30, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Milestone Pharmaceuticals and its competitors. According to the industry distribution chart, Milestone Pharmaceuticals ranks #338 out of 742 companies in the Biotechnology industry, placing it in the top 45.6%.
Is Milestone Pharmaceuticals' Buyback Yield % too high?
Milestone Pharmaceuticals' current Buyback Yield % is -6.63. Based on the distribution chart, Milestone Pharmaceuticals ranks #338 out of 742 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Milestone Pharmaceuticals has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does Milestone Pharmaceuticals' Buyback Yield % compare to TNYA and TLSA?
According to the Biotechnology industry distribution chart, Milestone Pharmaceuticals ranks #338 out of 742 companies for Buyback Yield %. This puts Milestone Pharmaceuticals in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Biotechnology company?
A good Buyback Yield % depends on the Biotechnology industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Milestone Pharmaceuticals and its competitors. Milestone Pharmaceuticals's current Buyback Yield % is -6.63. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Milestone Pharmaceuticals stock overvalued right now?
Milestone Pharmaceuticals (MIST) has a current Buyback Yield % of -6.63. The current Buyback Yield % is -6.63. Milestone Pharmaceuticals' overall GF Score™ is 26/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Milestone Pharmaceuticals (MIST), the current Buyback Yield % is -6.63 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Milestone Pharmaceuticals Business Description

Address 1111 Dr. Frederik-Phillips Boulevard, Suite 420, Montreal, QC, CAN, H4M 2X6
Milestone Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of cardiovascular medicines. Its approved product CARDAMYST (etripamil) nasal spray is available in the United States and is the self-administered treatment for use by patients anywhere, anytime an attack of PSVT occurs. It operates in single segment.
26GF Score

Get the complete analysis for MIST

Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.36
Price